| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.053 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.05 |
0.9 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |